EtoposideAntineoplastic Agents, PhytogenicDrug Screening Assays, AntitumorAntineoplastic AgentsXenograft Model Antitumor AssaysAntineoplastic Combined Chemotherapy ProtocolsTopoisomerase II InhibitorsCisplatinIfosfamideDoxorubicinCarcinoma, Small CellCell Line, TumorDNA Topoisomerases, Type IIPodophyllotoxinAntibiotics, AntineoplasticCyclophosphamideVincristineLeukemia P388Lung NeoplasmsTumor Cells, CulturedAmsacrineDrug Administration ScheduleMice, NudeApoptosisCarboplatinCombined Modality TherapyNeoplasms, ExperimentalNeoplasm TransplantationBleomycinNeoplasmsSarcoma 180Melanoma, ExperimentalDrug SynergismDose-Response Relationship, DrugDrug Resistance, NeoplasmCytarabineTeniposideCamptothecinCell SurvivalMice, Inbred BALB CLeukemia L1210GerminomaCancer VaccinesTopoisomerase I InhibitorsAntigens, NeoplasmAdministration, OralTreatment OutcomeLeukopeniaTopoisomerase InhibitorsMitoxantronePaclitaxelInfusions, IntravenousImmunotherapyNucleic Acid Synthesis InhibitorsDNA DamageTopotecanTransplantation, AutologousRemission InductionMice, Inbred C57BLCell ProliferationDrug EvaluationCarmustineTesticular NeoplasmsSurvival AnalysisHodgkin DiseaseDrug ResistanceMice, SCIDImmunotherapy, AdoptiveNeoplasms, Germ Cell and EmbryonalSurvival RateTransplantation, HeterologousRazoxaneInhibitory Concentration 50Lymphoma, Non-HodgkinDisease-Free SurvivalHematologic DiseasesEnediynesSalvage TherapyProdrugsDrug Resistance, MultipleVinblastineNeutropeniaOrganophosphorus CompoundsAntineoplastic Agents, AlkylatingP-GlycoproteinAntibodies, MonoclonalMelphalanCell CycleThrombocytopeniaEllipticinesDaunorubicinHL-60 CellsCell DivisionColonic NeoplasmsMelanomaTime FactorsFlow CytometryCarcinoma, Lewis LungGenetic TherapyEnzyme Inhibitors